STOCK TITAN

[Form 4] DaVita Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

DaVita Inc. director Barbara J. Desoer, through an attorney-in-fact, reported acquiring 369 shares of DaVita common stock on 08/15/2025 at no cash price indicated on the form and holds 369 shares directly following the transaction. The filing shows she also has indirect beneficial ownership of 12,659 shares through the Marc J. Desoer and Barbara J. Desoer 1998 Trust dated September 7, 1998. The Form 4 was signed by Stephanie N. Berberich as attorney-in-fact on 08/19/2025.

La amministratrice di DaVita Inc., Barbara J. Desoer, tramite una procuratrice, ha dichiarato di aver acquistato 369 azioni ordinarie DaVita il 15/08/2025 a un prezzo in contanti non indicato nel modulo e detiene direttamente 369 azioni a seguito della transazione. Il deposito indica inoltre che possiede per beneficiario indiretto 12.659 azioni tramite il Marc J. Desoer and Barbara J. Desoer 1998 Trust con data 7 settembre 1998. Il Modulo 4 è stato firmato da Stephanie N. Berberich in qualità di procuratrice il 19/08/2025.

La directora de DaVita Inc., Barbara J. Desoer, a través de una apoderada, informó haber adquirido 369 acciones ordinarias de DaVita el 15/08/2025 a un precio en efectivo no indicado en el formulario y mantiene 369 acciones en propiedad directa tras la operación. La presentación también muestra que posee indirectamente 12.659 acciones a través del Marc J. Desoer and Barbara J. Desoer 1998 Trust con fecha 7 de septiembre de 1998. El Formulario 4 fue firmado por Stephanie N. Berberich como apoderada el 19/08/2025.

DaVita Inc. 이사인 Barbara J. Desoer는 대리인을 통해 2025년 8월 15일에 DaVita 보통주 369주를 매수했다고 신고했으며, 양식에는 현금 가격이 기재되지 않았고 해당 거래 후 직접 369주를 보유하고 있습니다. 해당 제출서류에는 그녀가 1998년 9월 7일자 Marc J. Desoer and Barbara J. Desoer 1998 Trust를 통해 간접적으로 12,659주를 소유하고 있음을 또한 표시하고 있습니다. Form 4는 2025년 8월 19일 대리인 자격으로 Stephanie N. Berberich가 서명했습니다.

La administratrice de DaVita Inc., Barbara J. Desoer, a déclaré, par l'intermédiaire d'une mandataire, avoir acquis 369 actions ordinaires DaVita le 15/08/2025, à un prix en numéraire non indiqué sur le formulaire, et détient directement 369 actions après la transaction. Le dépôt indique également qu'elle détient indirectement 12 659 actions via le Marc J. Desoer and Barbara J. Desoer 1998 Trust daté du 7 septembre 1998. Le formulaire 4 a été signé par Stephanie N. Berberich en tant que mandataire le 19/08/2025.

Die Direktorin von DaVita Inc., Barbara J. Desoer, meldete über eine Bevollmächtigte den Erwerb von 369 DaVita-Stammaktien am 15.08.2025; ein Barpreis ist im Formular nicht angegeben. Nach der Transaktion hält sie unmittelbar 369 Aktien. Die Meldung weist außerdem eine indirekte wirtschaftliche Beteiligung an 12.659 Aktien über den Marc J. Desoer and Barbara J. Desoer 1998 Trust vom 7. September 1998 aus. Das Formular 4 wurde am 19.08.2025 von Stephanie N. Berberich als Bevollmächtigte unterschrieben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small insider acquisition by a director; immaterial to company valuation but shows insider buying.

The reported purchase of 369 shares by Director Barbara J. Desoer is a routine insider transaction disclosed on Form 4. Given the reported size (369 shares) relative to a public company of DaVita's scale, this trade is unlikely to be material to the companys capitalization or operations. The filing also confirms existing indirect ownership of 12,659 shares via a family trust, clarifying the reporting persons aggregate holdings. No derivative transactions or additional compensatory awards are reported.

TL;DR: Governance disclosure is complete for the transaction; filing follows Section 16 reporting protocols.

The Form 4 discloses the directors purchase and the trust-based indirect ownership, meeting Section 16(a) requirements. The filing was executed by an attorney-in-fact and includes the trustee-related indirect ownership attribution. There are no amendments, derivative instruments, or other unusual features reported that would raise governance concerns.

La amministratrice di DaVita Inc., Barbara J. Desoer, tramite una procuratrice, ha dichiarato di aver acquistato 369 azioni ordinarie DaVita il 15/08/2025 a un prezzo in contanti non indicato nel modulo e detiene direttamente 369 azioni a seguito della transazione. Il deposito indica inoltre che possiede per beneficiario indiretto 12.659 azioni tramite il Marc J. Desoer and Barbara J. Desoer 1998 Trust con data 7 settembre 1998. Il Modulo 4 è stato firmato da Stephanie N. Berberich in qualità di procuratrice il 19/08/2025.

La directora de DaVita Inc., Barbara J. Desoer, a través de una apoderada, informó haber adquirido 369 acciones ordinarias de DaVita el 15/08/2025 a un precio en efectivo no indicado en el formulario y mantiene 369 acciones en propiedad directa tras la operación. La presentación también muestra que posee indirectamente 12.659 acciones a través del Marc J. Desoer and Barbara J. Desoer 1998 Trust con fecha 7 de septiembre de 1998. El Formulario 4 fue firmado por Stephanie N. Berberich como apoderada el 19/08/2025.

DaVita Inc. 이사인 Barbara J. Desoer는 대리인을 통해 2025년 8월 15일에 DaVita 보통주 369주를 매수했다고 신고했으며, 양식에는 현금 가격이 기재되지 않았고 해당 거래 후 직접 369주를 보유하고 있습니다. 해당 제출서류에는 그녀가 1998년 9월 7일자 Marc J. Desoer and Barbara J. Desoer 1998 Trust를 통해 간접적으로 12,659주를 소유하고 있음을 또한 표시하고 있습니다. Form 4는 2025년 8월 19일 대리인 자격으로 Stephanie N. Berberich가 서명했습니다.

La administratrice de DaVita Inc., Barbara J. Desoer, a déclaré, par l'intermédiaire d'une mandataire, avoir acquis 369 actions ordinaires DaVita le 15/08/2025, à un prix en numéraire non indiqué sur le formulaire, et détient directement 369 actions après la transaction. Le dépôt indique également qu'elle détient indirectement 12 659 actions via le Marc J. Desoer and Barbara J. Desoer 1998 Trust daté du 7 septembre 1998. Le formulaire 4 a été signé par Stephanie N. Berberich en tant que mandataire le 19/08/2025.

Die Direktorin von DaVita Inc., Barbara J. Desoer, meldete über eine Bevollmächtigte den Erwerb von 369 DaVita-Stammaktien am 15.08.2025; ein Barpreis ist im Formular nicht angegeben. Nach der Transaktion hält sie unmittelbar 369 Aktien. Die Meldung weist außerdem eine indirekte wirtschaftliche Beteiligung an 12.659 Aktien über den Marc J. Desoer and Barbara J. Desoer 1998 Trust vom 7. September 1998 aus. Das Formular 4 wurde am 19.08.2025 von Stephanie N. Berberich als Bevollmächtigte unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DESOER BARBARA J

(Last) (First) (Middle)
C/O DAVITA INC.
2000 16TH STREET

(Street)
DENVER CO 80202

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DAVITA INC. [ DVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2025 A 369 A $0 369 D
Common Stock 12,659 I Marc J. Desoer and Barbara J. Desoer 1998 Trust dated September 7, 1998
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Stephanie N. Berberich, Attorney-in-Fact 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Barbara J. Desoer report on the DaVita (DVA) Form 4?

She reported acquiring 369 shares of DaVita common stock on 08/15/2025 and holds 369 shares directly after the transaction.

Does the Form 4 show any derivative or option transactions for DVA?

No. Table II (derivative securities) contains no reported transactions or holdings.

How many shares does Barbara J. Desoer indirectly own in DVA?

12,659 shares are reported as indirectly beneficially owned through the Marc J. Desoer and Barbara J. Desoer 1998 Trust dated September 7, 1998.

When was the Form 4 signed and by whom?

Signed by Stephanie N. Berberich, Attorney-in-Fact, on 08/19/2025.

Was a purchase price disclosed for the 369 shares on the Form 4?

No explicit price is listed on the form; the transaction is coded as an acquisition (A) with amount 369 and price field indicated as $0 on the form.
Davita Inc

NYSE:DVA

DVA Rankings

DVA Latest News

DVA Latest SEC Filings

DVA Stock Data

9.77B
35.76M
49.99%
52.46%
8.24%
Medical Care Facilities
Services-misc Health & Allied Services, Nec
Link
United States
DENVER